Liver Drugs

The U.S. Food and Drug Administration sent a letter to doctors highlighting potential negative side effects from Intercept Pharmaceuticals Inc (NASDAQ: ICPT)'s liver disease medicine called Ocaliva. The FDA said in its letter that if it is incorrectly dosed in patients with moderate to severe...

Morgan Stanley's Andrew Berens downgraded shares of Cempra Inc (NASDAQ: CEMP) to Underweight from Overweight with a price target slashed to $5 from $35 following the U.S. Food and Drug Administration's vote. The FDA's Antimicrobial Disease Advisory Committee voted in favor of Cempra...